Evidence map›Paper›PMID 35873263›Full record

ArticleFrontiers in psychiatry2022

Subtypes in Patients Taking Prescribed Opioid Analgesics and Their Characteristics: A Latent Class Analysis.

Christian Rauschert, Nicki-Nils Seitz, Sally Olderbak, Oliver Pogarell, Tobias Dreischulte, Ludwig Kraus

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christian RauschertDepartment of Epidemiology and Diagnostics, IFT Institut Für Therapieforschung, Munich, Germany.
Nicki-Nils SeitzDepartment of Epidemiology and Diagnostics, IFT Institut Für Therapieforschung, Munich, Germany.
Sally OlderbakDepartment of Epidemiology and Diagnostics, IFT Institut Für Therapieforschung, Munich, Germany.
Oliver PogarellDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität, Munich, Germany.
Tobias DreischulteDepartment of General Practice and Family Medicine, Ludwig-Maximilians-Universität, Munich, Germany.
Ludwig KrausDepartment of Epidemiology and Diagnostics, IFT Institut Für Therapieforschung, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Owing to their pharmacological properties the use of opioid analgesics carries a risk of abuse and dependence, which are associated with a wide range of personal, social, and medical problems. Data-based approaches for identifying distinct patient subtypes at risk for prescription opioid use disorder in Germany are lacking. Objective: This study aimed to identify distinct subgroups of patients using prescribed opioid analgesics at risk for prescription opioid use disorder. Methods: Latent class analysis was applied to pooled data from the 2015 and 2021 Epidemiological Survey of Substance Abuse. Participants were aged 18-64 years and self-reported the use of prescribed opioid analgesics in the last year ( Results: Three classes were extracted, which were labeled as Conclusion: The results add further evidence to the knowledge that patients using prescribed opioid analgesics are not a homogeneous group of individuals whose needs lie in pain management alone. Rather, it becomes clear that these patients differ in their individual risk of a prescription opioid use disorder, and therefore identification of specific risks plays an important role in early prevention.

Indexed as

DSM-5epidemiological surveylatent class analysisopioid analgesicsopioid use disorderprescription

Identifiers

PMID35873263
PMCPMC9304960

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.